PSMA PET (PET/CT or PET/MRI) is transforming prostate cancer management. PSMA stands for prostate-specific membrane antigen. These scans help doctors stage the disease, detect early signs of recurrence, and choose the most appropriate treatment. They are especially helpful for individuals with unfavorable intermediate, high, or very high-risk prostate cancer, as well as those experiencing a rising PSA after treatment.

During this webinar, experts will discuss when to request a PSMA PET scan, how the results may impact your care, and what to expect before and after the scan

What You Will Learn:

• Who benefits most: people newly diagnosed with high-risk disease and survivors with a rising PSA.
• How the scan works: PET with CT or MRI, and the tracers commonly used in prostate cancer diagnosis.
• When it is used: when PSMA PET is first-line imaging or combined with a CT or bone scan, and how the results can influence treatment, from targeted radiation to systemic therapy or a clinical trial.
• Coverage and access: what insurance typically covers, how to check authorization, and how to prepare for the appointment.
• What to ask your doctor: the best timing based on PSA level, which tracer to use, and next steps if the scan detects disease.